neurodegenerative disease drugs - Statistics

General Stats
  • This quiz has been taken 10 times
  • The average score is 20 of 34
Answer Stats
Hint Answer % Correct
what is Parkinson's disease characterised by? insidious onset, with slowing of voluntary movement, muscular rigidity, postural abnormality & tremors
100%
what are the 3 distinguishing features of Alzheimer's disease? accumulation of senile plaques (b-amyloid accumulations)
86%
formation of numerous neurofibrillary tangles
86%
what are examples of each? levodopa
86%
what are the drugs used to treat Alzheimer's disease? acetylcholinesterase inhibitors
71%
allosterically binding to GABAA receptors on post- synaptic neurons
71%
amantadine
71%
what is an example of a motor neuron disease? amyotrophic lateral sclerosis (ALS) etc
71%
carbidopa
71%
what is an example of each? donepezil, rivastigmine, etc
71%
what drugs do we use to treat Parkinson's? dopamine precursors
71%
dopamine receptor agonists
71%
loss of cortical neurons (especially cholinergic neurons)
71%
what are the physical effects of motor neuron disease? loss of motor neurons and muscle control until the patient can no longer eat, speak, move or breathe, with respiratory failure being the usual cause of death
71%
memantine
71%
what is the mechanism of action of each? metabolic precursor of dopamine, that is converted to dopamine by aromatic L-amino acid decarboxylase (AADC)
71%
benzatropine
57%
what are the mechanisms of action of the first drug thought to be? binding to glutamate receptors to reduce the release of glutamate
57%
inhibitors of dopamine metabolism
57%
NMDA receptor antagonists
57%
preferentially blocking TTX-sensitive sodium channels, which are linked to neuronal damage
57%
what are the drugs indicated specifically for motor neuron disease? riluzole, baclofen, edaravone, tizanidine
57%
what is Parkinson's disease caused by? the striatal deficiency of dopamine following neuronal degeneration within the substantia nigra
57%
uncompetitive antagonists at glutamatergic NMDA receptors
57%
what is motor neuron disease? a group of related neurodegenerative diseases that affect motor neurons and therefore voluntary muscle control
43%
antimuscarinic drugs
43%
bromocriptine, pramipexole, etc
43%
what is the mechanism of action of each? preferentially inhibits acetylcholinesterase (AchE) in the CNS over peripheral enzymes
43%
what does pharmacological treatment aim to do for Parkinson's? restore dopamine levels in basal ganglia
43%
inhibits AADC in peripheral tissues to increase availability of levodopa in the CNS by allowing more to cross the BBB before being converted to dopamine
29%
selectively blocks activity at the M1 muscarinic acetylcholine receptor, reducing cholinergic activity in the basal ganglia and restoring the ‘balance’ of acetylcholine and dopamine
29%
unknown, but thought to weakly inhibit the NMDA and nicotine receptors, as well as activate dopamine receptors
14%
agonists at dopamine D2 receptors, working to restore dopamine signalling in the striatum
0%
reduce the excitatory effect of acetylcholine
0%
No matching quizzes found
Score Distribution
Percent of People with Each Score
Percentile by Number Answered
Your Score History
You have not taken this quiz